A surprising role for uric acid: The inflammatory malaria response

Current Rheumatology Reports

Volumn 16, Issue 2, 2014, Pages

  Gallego Delgado, Julio ^a   Ty, Maureen ^a   Orengo, Jamie M ^b   De Hoef, Diana Van ^c   Rodriguez, Ana ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

^c NEW YORK ACADEMY OF SCIENCES   (United States)

Author keywords

Cerebral malaria; Cytokines; Inflammation; Inflammatory; Innate immunity; Malaria; Plasmodium; Plasmodium falciparum; Uric acid; Uricase

Indexed keywords

ACETYLCYSTEINE; ALLOPURINOL; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYPOXANTHINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; QUININE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; URIC ACID; AUTACOID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN MALARIA; COMBINATION CHEMOTHERAPY; CYTOKINE RELEASE; DENDRITIC CELL; ERYTHROCYTE; HUMAN; HYPERURICEMIA; INFLAMMATION; MALARIA; MALARIA FALCIPARUM; MONOTHERAPY; NONHUMAN; PLASMODIUM; T LYMPHOCYTE; URIC ACID BLOOD LEVEL; ANIMAL; BLOOD; HOST PARASITE INTERACTION; METABOLISM; PARASITOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ERYTHROCYTES; HOST-PARASITE INTERACTIONS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MALARIA; PLASMODIUM; URIC ACID;

EID: 84896702802     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-013-0401-8     Document Type: Article

References (58)

1. Golgi C. Sull Infezione malarica. Arch Sci Med (Torino). 1886;10: 109-1.
2. Kwiatkowski D. Malarial toxins and the regulation of parasite density. Parasitol Today. 1995;11:206-12.
3. Clark IA, Cowden WB. The pathophysiology of falciparum malaria. Pharmacol Ther. 2003;99:221-60.
4. Haldar K and Mohandas N. Malaria, erythrocytic infection, and anemia. Hematology AmSoc Hematol Educ Program. 2009;87-93.
5. van der Heyde HC, Nolan J, Combes V, et al. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006;22:503-8.
6. Schofield L, Hackett F. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med. 1993;177:145-53.
7. Coban C, Ishii KJ, Kawai T, et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med. 2005;201:19-25.
8. Griffith JW, Sun T, McIntosh MT, Bucala R. Pure Hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol. 2009;183:5208-20.
9. Parroche P, Lauw FN, Goutagny N, et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc Natl Acad Sci U S A. 2007;104:1919-24.
10. Sharma S, DeOliveira RB, Kalantari P, et al. Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity. 2011;35:194-207.
11. Wu X, Gowda NM, Kumar S, Gowda DC. Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J Immunol. 2010;184: 4338-48.
12. Gowda NM, Wu X, Gowda DC. The nucleosome (histone-DNA complex) is the TLR9-specific immunostimulatory component of Plasmodium falciparum that activates DCs. PLoS One. 2011;6: e20398.
13. Erdman LK, Finney CA, Liles WC, Kain KC. Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity. Mol Biochem Parasitol. 2008;162:105-11.
14. Busso N, So A. Mechanisms of inflammation in gout. Arthritis Res Ther. 2010;12:206.
15. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003;425:516-21.
16. Gero AM, O'Sullivan WJ. Purines and pyrimidines in malarial parasites. Blood Cells. 1990;16:467-84. discussion 485-98.
17. Asahi H, Kanazawa T, Kajihara Y, et al. Hypoxanthine: a low molecular weight factor essential for growth of erythrocytic Plasmodium falciparum in a serum-free medium. Parasitology. 1996;113(Pt 1):19-23.
18. Orengo JM, Evans JE, Bettiol E, et al. Plasmodium-induced inflammation by uric acid. PLoS Pathog. 2008;4:e1000013.
19. Orengo JM, Leliwa-Sytek A, Evans JE, et al. Uric acid is a mediator of the Plasmodium falciparum-induced inflammatory response. PLoS One. 2009;4:e5194. This work shows inflammation by uric acid derived from the human parasite Plasmodium falciparum.
20. Reyes P, Rathod PK, Sanchez DJ, et al. Enzymes of purine and pyrimidine metabolism from the human malaria parasite, Plasmodium falciparum. Mol Biochem Parasitol. 1982;5: 275-90.
21. Heath WR, Carbone FR. Immunology: dangerous liaisons. Nature. 2003;425:460-1.
22. Guermonprez P, Helft J, Claser C, et al. Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med. 2013;19:730-8.
23. van de Hoef DL, Coppens I, Holowka T, et al. Plasmodium falciparum-derived uric acid precipitates induce maturation of dendritic cells. PLoS One. 2013;8:e55584.
24. Overgaard-Hansen K, Lassen UV. Active transport of uric acid through the human erythrocyte membrane. Nature. 1959;184: 553-4.
25. Grau GE, Piguet PF, Vassalli P, Lambert PH. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev. 1989;112:49-70.
26. Kwiatkowski D, Hill AV, Sambou I, et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990;336:1201-4.
27. Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther. 2008;324:1-7.
28. Glantzounis GK, Tsimoyiannis EC, Kappas AM, Galaris DA. Uric acid and oxidative stress. Curr Pharm Des. 2005;11:4145-51.
29. Alvarez-Lario B, Macarron-Vicente J. Uric acid and evolution. Rheumatology (Oxford). 2010;49:2010-5.
30. Johnson RJ, Andrews P, Benner SA, Oliver W. Theodore E. Woodward award. The evolution of obesity: insights from the mid-Miocene. Trans Am Clin Climatol Assoc. 2010;121:295-305. discussion 305-8.
31. Johnson RJ, Titte S, Cade JR, et al. Uric acid, evolution and primitive cultures. Semin Nephrol. 2005;25:3-8.
32. Smyth CJ and Holers VM, Gout, hyperuricemia, and other crystal-associated arthropathies. 1999, New York: M. Dekker. xvii, 401 p.
33. Bertrand KE, Mathieu N, Inocent G, Honore FK. Antioxidant status of bilirubin and uric acid in patients diagnosed with Plasmodium falciparum malaria in Douala. Pak J Biol Sci. 2008;11:1646-9.
34. Das BS, Patnaik JK,Mohanty S, et al. Plasma antioxidants and lipid peroxidation products in falciparum malaria. Am J Trop Med Hyg. 1993;49:720-5.
35. Iwalokun BA, Bamiro SB, OgunledunA. Levels and interactions of plasma xanthine oxidase, catalase and liver function parameters in Nigerian children with Plasmodium falciparum infection. Apmis. 2006;114:842-50.
36. Lopera-Mesa TM, Mita-Mendoza NK, van de Hoef DL, et al. Plasma uric acid levels correlate with inflammation and disease severity in Malian children with Plasmodium falciparum malaria. PLoS One. 2012;7:e46424.
37. Mita-Mendoza NK, van de Hoef DL, Lopera-Mesa TM, et al. A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malaria. PLoS One. 2013;8:e54481.
38. Mishra SK, Das BS. Malaria and acute kidney injury. Semin Nephrol. 2008;28:395-408.
39. ZhouY, Fang L, Jiang L, et al.Uric acid induces renal inflammation via activating tubular NF-kappaB signaling pathway. PLoS One. 2012;7:e39738.
40. Sarma PS, Mandal AK, Khamis HJ. Allopurinol as an additive to quinine in the treatment of acute complicated falciparum malaria. Am J Trop Med Hyg. 1998;58:454-7.
41. Marr JJ. Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis. J Lab Clin Med. 1991;118:111-9.
42. Gillman BM, Batchelder J, Flaherty P,WeidanzWP. Suppression of Plasmodium chabaudi parasitemia is independent of the action of reactive oxygen intermediates and/or nitric oxide. Infect Immun. 2004;72:6359-66.
43. Kanellis J, Kang DH. Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease. Semin Nephrol. 2005;25:39-42.
44. Jin M, Yang F, Yang I, et al. Uric acid, hyperuricemia and vascular diseases. Front Biosci (Landmark Ed). 2012;17:656-69.
45. Watt G, Jongsakul K, Ruangvirayuth R. A pilot study of Nacetylcysteine as adjunctive therapy for severe malaria. QJM. 2002;95:285-90.
46. Rasti N, Wahlgren M, Chen Q. Molecular aspects of malaria pathogenesis. FEMS Immunol Med Microbiol. 2004;41: 9-26.
47. Hunt NH, Grau GE. Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol. 2003;24: 491-9.
48. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183-90.
49. Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008;27: 608-19.
50. Schwartz IF, Grupper A, Chernichovski T, et al. Hyperuricemia attenuates aortic nitric oxide generation, through inhibition of arginine transport, in rats. J Vasc Res. 2011;48:252-60.
51. Zharikov S, Krotova K, Hu H, et al. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells. Am J Physiol Cell Physiol. 2008;295: C1183-90.
52. Tomiyama H, Higashi Y, Takase B, et al. Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am J Hypertens. 2011;24:770-4.
53. Hanson SR, Harker LA. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl- L-arginyl chloromethyl ketone. ProcNatl Acad SciU S A. 1988;85: 3184-8.
54. Combes V, Coltel N, Faille D, et al. Cerebral malaria: role of microparticles and platelets in alterations of the blood-brain barrier. Int J Parasitol. 2006;36:541-6.
55. Martinon F, Petrilli V, Mayor A, et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440: 237-41.
56. Reimer T, Shaw MH, Franchi L, et al. Experimental cerebral malaria progresses independently of the Nlrp3 inflammasome. Eur J Immunol. 2010;40:764-9.
57. Kordes M, Matuschewski K, Hafalla JC. Caspase-1 activation of interleukin-1beta (IL-1beta) and IL-18 is dispensable for induction of experimental cerebral malaria. Infect Immun. 2011;79:3633-41.
58. Kanbay M, Segal M, Afsar B, et al. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013;99: 759-66.